SLC6A6 and Alzheimer disease: Our goal is to directly learn the underlying spatiotemporal dynamics of AD biomarkers from clinical PET imaging data by inferring the governing PDEs that describe the propagation of amyloid-βA, tauτ, and neurodegeneration N across the brain.